Sanofi spins up AI pact, inking $140M deal to apply Aqemia’s physics algorithms to drug discovery

Another day, another artificial intelligence (AI) deal. Tuesday was Sanofi’s turn to partner up, striking a deal worth up to $140 million to work on the discovery of small molecules with its compatriot Aqemia.